Form 4: BeiGene Director Wang Xiaodong Executes Stock Sales Under 10b5-1 Plan

Director Wang Xiaodong of BeiGene, Ltd. reports the sale of American Depositary Shares (ADS) under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 18, 2025, Wang Xiaodong, a director of BeiGene, Ltd., executed multiple sales of American Depositary Shares (ADS).
• The sales were conducted under a Rule 10b5-1 trading plan adopted on August 12, 2024.
• A total of 41,760 ADS were sold at weighted average prices ranging from $258.2542 to $264.0123.
• The transactions resulted in a decrease in the number of ADS directly owned by Wang Xiaodong.
• Wang Xiaodong also exercised options to acquire 542,880 ordinary shares at a price of $0.50.
• Wang Xiaodong disclaims beneficial ownership of shares held by a family trust and Wang Investment LLC.
• Each American Depositary Share represents 13 Ordinary Shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, as it simply reports facts.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. The use of a 10b5-1 trading plan suggests that the sales were pre-planned and not based on any inside information.

Key Dates

Keywords

BeiGene, Wang Xiaodong, ADS, American Depositary Shares, Rule 10b5-1, Director, Share Sale, Form 4, Beneficial Ownership, BGNE